SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating beta-catenin signaling. Liu GY, Huang DP, Ge C, Li XY, et al. Clin Breast Cancer 2025 Aug 7:S1526-8209(25)00227.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu GY, Huang DP, Ge C, Li XY, et al. SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating beta-catenin signaling. Clin Breast Cancer 2025 Aug 7:S1526-8209(25)00227.
PMID: 40887336